Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VENUS study: Early postoperative enoxaparin for VTE prevention in gynecologic surgery
jRCTs051240203Recruiting
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of enoxaparin in pulmonary embolism (PE) and deep vein thrombosis (DVT), sponsored by Japan Society for the Promotion of Science. Primary endpoint: Incidence of Major Bleeding. Started Dec 2024; status: recruiting.
02
Drugs
enoxaparin
03
Conditions
pulmonary embolism (PE)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on jRCTs051240203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240203.